Nanobody-peptide-conjugate (NPC) for passive immunotherapy against SARS-CoV-2 variants of concern (VoC): a prospective pan-coronavirus therapeutics

por Panda, Mamta, Kalita, Elora, Singh, Satyendra, Kumar, Ketan, Prajapati, Vijay Kumar
Publicado 2022

MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapies

por Panda, Mamta, Kalita, Elora, Singh, Satyendra, Kumar, Ketan, Rao, Abhishek, Prajapati, Vijay Kumar
Publicado 2022